The Janus kinase (JAK) inhibitor tofactitinib that is used to treat autoimmune diseases such as ulcerative colitis and rheumatoid arthritis may also have potential as a treatment for coeliac disease, according to gastroenterologists in Europe. Clinicians in Belgium have found that a man using tofactitinib to treat alopecia also had remission in a his celiac ...
Coeliac disease may be eased by JAK inhibitor
By Michael Woodhead
28 Jul 2020